BIOCARDIA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3762 USD | -2.82% |
|
-0.87% | -43.36% |
| 04-30 | Transcript : BioCardia, Inc. - Special Call | |
| 04-25 | BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort | CI |
Chart calendar BioCardia, Inc.
b54a704bcb42d0b.LuK8wxJE2y42ygX2xVgHab0r2G0vjiLhGGGgseTv0cs.FpHrk2obomRmrCiMmjt_OfBjsSx7xBqxaSX634CYp71-uM6NTQmBalXnPQ~63efe80ca41cd204d3039c94920edc43
Upcoming events on BioCardia, Inc.
Past events on BioCardia, Inc.
| 30/04/2024 20:00 | Business Update Call |
| 27/03/2024 20:30 | Q4 2023 Earnings Call |
| 27/03/2024 20:00 | Q4 2023 Earnings Release |
| 03/03/2024 | Technology and Heart Failure Therapeutics Conference |
| 08/11/2023 21:30 | Q3 2023 Earnings Call |
| 08/11/2023 21:11 | Q3 2023 Earnings Release |
| 18/10/2023 17:00 | Annual General Meeting |
| 09/08/2023 21:30 | Q2 2023 Earnings Call |
| 09/08/2023 21:05 | Q2 2023 Earnings Release |
| 11/07/2023 | Data Safety Monitoring Board Meeting |
| 10/05/2023 21:30 | Q1 2023 Earnings Call |
| 10/05/2023 21:05 | Q1 2023 Earnings Release |
| 29/03/2023 21:30 | Q4 2022 Earnings Call |
| 29/03/2023 13:15 | Q4 2022 Earnings Release |
| 09/11/2022 21:30 | Q3 2022 Earnings Call |
| 09/11/2022 21:05 | Q3 2022 Earnings Release |
| 24/10/2022 | LD Micro Main Event XV |
| 05/10/2022 13:55 | Heart Failure Society of America Meeting |
| 14/09/2022 | Cantor Fitzgerald Cell & Gene Therapy Conference |
| 11/09/2022 | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,71 0,57 25.44% | 0,15 0,12 20.83% | 1,02 0,77 31.87% | 1,35 1,39 -2.45% | 0,48 0,70 -31.86% | 0,70 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -12,6 -11,5 -9.3% | -11,8 -12,9 8.38% | -11,6 -13,2 12.42% | -16,0 |
|
EBIT Million USD | Released Forecast Spread | -14,2 -14,5 1.75% | -15,5 -15,9 2.37% | -12,6 -13,7 7.95% | -11,9 -12,6 5.76% | -11,6 -13,2 11.79% | -16,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,7 -15,0 1.92% | -15,0 -16,0 6.32% | -12,6 -14,1 10.35% | -11,9 -12,9 7.7% | -11,6 -13,1 11.67% | -15,7 |
|
Net income Million USD | Released Forecast Spread | -14,7 -15,0 1.92% | -15,0 -15,9 5.57% | -12,6 -13,6 7.5% | -11,9 -12,6 5.68% | -11,6 -13,1 11.67% | -15,7 |
|
EPS USD | Released Forecast Spread | -2,61 -2,75 5.09% | -1,48 -1,57 5.93% | -0,75 -0,77 2.6% | -0,67 -0,72 6.29% | -0,55 -0,46 -19.57% | -0,42 |
| Announcement Date | 09/04/20 | 30/03/21 | 29/03/22 | 29/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,08 0,03 163.33% | 0,06 0,19 -68.42% | 0,97 0,07 1311.59% | 0,21 0,11 87.61% | 0,11 0,15 -30.72% | 0,06 0,34 -81.18% | 0,04 0,18 -76.57% | 0,36 0,04 827.27% | 0,01 0,19 -93.16% |
|
EBITDA Million USD | Released Forecast Spread | -3,45 -2,40 -43.58% | -3,31 -3,00 -10.37% | -2,48 -3,50 29.14% | -3,03 -3,60 15.81% | -3,00 -4,00 25.08% | -3,49 -2,90 -20.28% | -3,43 -3,40 -0.91% | -2,58 -4,00 35.58% | -2,06 -3,60 42.67% |
|
EBIT Million USD | Released Forecast Spread | -3,46 -4,82 28.17% | -3,33 -2,73 -21.82% | -2,50 -5,00 50.04% | -3,06 -4,03 24.12% | -3,02 -3,47 13.13% | -3,45 -3,53 2.07% | -2,60 -3,73 30.26% | -2,08 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,46 -4,11 15.69% | -3,33 -2,81 -18.14% | -2,50 -4,95 49.59% | -3,06 -3,99 23.39% | -3,03 -4,00 24.3% | -3,50 -2,70 -29.67% | -3,42 -3,40 -0.71% | -2,57 -4,00 35.65% | -2,07 -3,60 42.44% |
|
Net income Million USD | Released Forecast Spread | -3,46 -3,94 12.22% | -3,33 -2,81 -18.14% | -2,50 -4,57 45.36% | -3,06 -3,92 22.07% | -3,03 -3,73 18.92% | -3,50 -2,70 -29.67% | -3,42 -3,46 1.04% | -2,57 -4,00 35.65% | -2,07 -3,60 42.44% |
|
EPS USD | Released Forecast Spread | -0,21 -0,19 -8.62% | -0,19 -0,18 -5.56% | -0,14 -0,26 45.1% | -0,17 -0,22 22.73% | -0,16 -0,21 21.95% | -0,17 -0,18 2.86% | -0,17 -0,17 0% | -0,12 -0,11 -9.09% | -0,09 -0,10 10% |
| Announcement Date | 29/03/22 | 11/05/22 | 10/08/22 | 09/11/22 | 29/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 27/03/24 |
More events
Past sector events for BioCardia, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BCDA Stock
- Calendar BioCardia, Inc.
